Nuclear Medicine and Biology
Volume 33, Issue 2 , Pages 173-183 , February 2006

Chemoselective hydrazone formation between HYNIC-functionalized peptides and 18F-fluorinated aldehydes

Received 2 September 2005 ,Revised 13 October 2005 ,Accepted 17 October 2005.

References 

  1. Okarvi SM. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur J Nucl Med. 2001;28:929–938
  2. Wester HJ, Hamacher K, Stöcklin G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl Med Biol. 1996;23:365–372
  3. Guhlke S, Coenen HH, Stöcklin G. Fluoroacylation agents based on small n.c.a. [18F]fluorocarboxylic acid. Appl Radiat Isotopes. 1994;45:715–727
  4. Vaidyannathan G, Zalutsky M. Improved synthesis of N-succinimidyl 4-[18F]fluoro-benzoate and its application to the labeling of a monoclonal antibody fragment. Bioconjug Chem. 1994;5:352–356
  5. Guhlke S, Wester HJ, Bruns C, Stöcklin G. (2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl Med Biol. 1994;21:819–825
  6. Wester HJ, Brockmann J, Rösch F, Wutz W, Herzog H, Smith-Jones P, et al. PET-pharmacokinetics of 18F-Octreotide: a comparison with 67Ga-DFO-Octreotide and 86Y-DTPA-Octreotide. Nucl Med Biol. 1997;24:275–286
  7. Vaidyanathan G, Zalutsky MR. Fluorine-18-labeled [Nle4, d-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue. Nucl Med Biol. 1997;24:171–178
  8. Moody TW, Leyton J, Unsworth E, John C, Lang L, Eckelman W. (Arg15, Arg21)VIP: evaluation of biological activity and localization to breast cancer tumors. Peptides. 1998;19:585–592
  9. Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, et al. Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 2001;61:1781–1785
  10. Fredriksson A, Ekberg K, Ingvar M, Johansson BL, Wahren J, Stone-Elander S. In vivo biodistribution and pharmacokinetics of 18F-labeled human C-peptide: evaluation in monkeys using positron emission tomography. Life Sci. 2002;71:1361–1370
  11. Bergmann R, Scheunemann M, Heichert C, Mäding P, Wittrisch H, Kretzschmar M, et al. Biodistribution and catabolism of 18F-labeled neurotension(8-13) analogs. Nucl Med Biol. 2002;29:61–72
  12. Lang L, Eckelman WC. One-step synthesis of 18F-labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. Appl Radiat Isot. 1994;45:1155–1163
  13. Magata Y, Lang L, Kiesewetter DO, Jagoda EM, Channing MA, Eckelman WC. Biologically stable [18F]-labeled benzylfluoride derivatives. Nucl Med Biol. 2000;27:163–168
  14. Poethko T, Thumshirn G, Hersel U, Rau F, Haubner R, Schwaiger M, et al. Improved tumor uptake, tumor retention and tumor/background ratios of pegylated RGD-multimers. J Nucl Med. 2003;44:46P;[abstr.148]
  15. Poethko T, Thumshirn G, Haubner R, Hauser A, Herz M, Kessler H, et al. Multimeric ligand systems for high contrast imaging of αvβ3 integrins. J Nucl Med. 2004;45:52P;[abstr. 150]
  16. Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, et al. Two-step methodology for high-yield routine radiohalogenation of peptides: 18F-labeled RGD and octreotide analogs. J Nucl Med. 2004;45:892–902
  17. Poethko T, Schottelius M, Thumshirn G, Herz M, Haubner R, Henriksen G, et al. Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation. Radiochim Acta. 2004;92:317–327
  18. Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, et al. First 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res. 2004;10:3593–3606
  19. Henriksen G, Schottelius M, Poethko T, Hauser A, Wolf I, Schwaiger M, et al. Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET. Eur J Nucl Med Mol Imaging. 2004;31:1653–1657
  20. Houdier S, Legrand M, Boturyn D, Croze S, Defranq E, Lhomme J. A new fluorescent probe for sensitive detection of carbonyl compounds. Anal Chim Acta. 1999;382:253–256
  21. Houdier S, Perrier S, Defranq E, Legrand M. A new fluorescent probe for sensitive detection of carbonyl compounds: sensitivity improvement and application to environmental water samples. Anal Chim Acta. 2000;412:221–233
  22. Gras-Masse H. Chemoselective ligation and antigen vectorization. Biologicals. 2001;29:183–188
  23. Bourel-Bonnet L, Pécheur EI, Grandjean C, Blanpain A, Baust T, Melnyk O, et al. Anchorage of synthetic peptides onto liposomes via hydrazone and α-oxo hydrazone bonds. Preliminary functional investigations. Bioconjug Chem. 2005;16:450–457
  24. Zubin EM, Stetsenke DA, Zatsepin TS, Gait MJ, Oretskaya TS. Oligonucleotides containing 2′-O-[2-(2,3-dihydroxypropyl)amino-2-oxoethyl]uridine as suitable precursors of 2′-aldehyde oligonucleotides for chemoselective ligation. Bioorg Med Chem. 2005;13:4912–4920
  25. Chang YS, Jeong JM, Lee YS, Kim HW, Rai GB, Lee SJ, et al. Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method. Bioconjug Chem. 2005;16:1329–1333
  26. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990;31:2022–2028
  27. Mäcke HR, Behe M. New octreotide derivatives labelled with technetium-99m. J Nucl Med. 1996;37:29;[abstr. 107]
  28. Dewanjee MK, Ghalfouripour AK, Subramanian M, Hanna M, Kapadvanjwala M, Serafini AN, et al. Labeling antisense deoxyoligonucleotide with Tc-99m and hybridation with c-myc oncogene mRNA in P388 leukemic cells. J Labelled Compd Radiopharm. 1994;35:40–42
  29. Babich JW, Fischman AJ. Effect of “co-ligand“ on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl Med Biol. 1995;22:25–30
  30. Edwards DS, Liu S, Harris AR, Poirier MJ, Ewels BA. 99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjug Chem. 1999;10:803–807
  31. Harris TD, Sworin M, Williams N, Rajopadhye M, Damphousse PR, Glowacka D, et al. Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of 99mTc-labeld radiopharmaceuticals. Bioconjug Chem. 1999;10:808–814
  32. Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Improvement of pharmacokinetics of radioiodinated Tyr3-octreotide by conjugation with carbohydrates. Bioconjug Chem. 2002;13:1021–1030
  33. Haka MH, Kilbourn MR, Watkins GL, Toorongian SA. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: improved synthesis of [18F]GBR-13119. J Labelled Compd Radiopharm. 1989;823–833
  34. Edward JT, Chubb FL, Sangster J. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilize iron from reticulocytes in vitro: reappraisal of reported partition coefficients. Can J Physiol Pharmacol. 1997;75:1362–1368
  35. Klyosov AA. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry. 1996;35:4457–4467
  36. Mutlib AE, Dickenson P, Chen SY, Espina RJ, Daniels JS, Gan LS. Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates. Chem Res Toxicol. 2002;15:1190–1207
  37. Padilla De Jesús OL, Ihre HR, Gagne L, Fréchet JMJ, Szoka FC. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem. 2002;13:453–461
  38. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Ann Rev Biochem. 1986;55:663–700
  39. Lee SH, Choi CS, Kim N, Choi DH, Park KH. Synthesis and characterization of bifunctional organic-glasses based on diphenylhydrazone and barbituric acid derivative for photorefractive application. Bull Korean Chem Soc. 2003;24:1793–1798
  40. Garnovskii DA, Pombeiro AJL, Haukka M, Sobota P, Kukushkin VY. Regioselective HON-addition of bifunctional hydrazone oximes to Pt(IV)-bound nitriles. Dalton Trans. 2004;7:1097–1103
  41. Guggenberg E, Mikolajczak R, Janota B, Riccabona G, Decristoforo C. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-d-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis. J Pharm Sci. 2004;93:2497–2506

PII: S0969-8051(05)00274-X

doi: 10.1016/j.nucmedbio.2005.10.010

Nuclear Medicine and Biology
Volume 33, Issue 2 , Pages 173-183 , February 2006

Article Tools

* Image Usage & Resolution